Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1570 of 6351
-
Can a simple protein improve recovery from heated chemo surgery?
Disease control Recruiting nowIntroduction Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is considered as the standard of care for the treatment of peritoneal metastases. Cytoreductive surgery with HIPEC is characterized by large intra operative fluid shift secondary to su…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment.
Phase 1/2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New inhaled drug aims to keep bronchiectasis patients Flare-Up free
Disease control Recruiting nowThis study is a phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose range finding study designed to explore the efficacy, safety, and tolerability of 2 active treatment regimens of CSL787 (immunoglobulin G \[IgG\] inhalation solution) compare…
Phase 2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill aims to quiet heartburn without damaging the esophagus
Symptom relief Not yet recruitingThis study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
Phase 3 • Sponsor: Onconic Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 14:58 UTC
-
Could a simple head tilt save stroke Patients' brains?
Disease control Recruiting nowRecent studies suggest that head-down positioning (HDP) intervention may improve outcomes in ischemic stroke. In the era of reperfusion therapy, a key protective strategy is to administer neuroprotective interventions before recanalization to reduce the loss of the ischemic penum…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 26, 2026 17:27 UTC
-
New eye drop shows promise for glaucoma patients in large trial
Disease control CompletedThis study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Phase 3 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New AI-Powered insulin system could free people with diabetes from constant meal calculations
Disease control Recruiting nowA randomized cross-over trial assessing glycemic control on Automated insulin delivery as Adaptive Network (AIDANET) algorithm when used in three modes: AIDANET-Fully Closed Loop (FCL), AIDANET-Hybrid Closed Loop (HCL) and AIDANET allowing a mix between FCL and HCL. There will be…
Sponsor: Sue Brown • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Breath training could ease lingering concussion symptoms in veterans
Symptom relief Recruiting nowMany combat veterans (c-Vs), service members (SMs) and civilians with mild traumatic brain injury (mTBI, also termed concussion) suffer from persistent post-concussion symptoms (PPCS) that degrade physical and cognitive well-being and have been linked with early neurodegeneration…
Phase 2/3 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 26, 2026 18:10 UTC
-
New pill could tame overactive thyroid in Graves' disease
Disease control Recruiting nowThis is a parallel group, Phase 2, 2-arm study to measure the treatment effect and safety of rilzabrutinib dose 1 or rilzabrutinib dose 2 in participants with Graves' disease, with and without Graves' orbitopathy, aged 18 years or older. Study details include: * Screening perio…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New eye drops aim to banish night glare after laser surgery
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if Phentolamine Ophthalmic Solution works to treat adults that have had keratorefractive surgery and have decreased visual acuity under mesopic conditions. It will also learn about the safety of Phentolamine Ophthalmic Solution. The mai…
Phase 3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Could an ADHD drug beat cancer fatigue in kids?
Symptom relief Recruiting nowCancer-related fatigue is a common and debilitating late effect in pediatric brain tumor survivors. Currently, evidence-based recommendations to ameliorate this condition are lacking. The researchers will investigate the ability of methylphenidate to improve fatigue and cognitio…
Phase 3 • Sponsor: Odense University Hospital • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Brain tumor drug vorasidenib tested in everyday practice
Disease control OngoingThe goal of this Study is to evaluate the effectiveness and safety of Vorasidenib in Patients with Isocitrate dehydrogenase IDH1/2 mutant Grade 2 astrocytoma or oligodendroglioma, primary purposeis to evaluate the efficectiveness of Vorasidenib in glioma patients treated in routi…
Sponsor: Servier (Tianjin) Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Micro workouts, macro impact: can 5-Minute exercise snacks beat workplace stress?
Symptom relief Recruiting nowTo create brief exercise videos addressing physical discomfort, fitness goals, and movement skills. To design personalized exercise menus to enhance staff adherence. To apply the "exercise snacking" model with multiple short daily sessions and evaluate its effects on health, wo…
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can Weight-Loss surgery reshape the mind as well as the body?
Knowledge-focused Recruiting nowThis prospective observational study evaluates the effect of bariatric surgery on mental health and hair cortisol in patients with morbid obesity over a 3-year follow-up. Assessments will be performed before surgery and at 1 month, 1 year, 2 years, and 3 years to analyze psycholo…
Sponsor: University of Alicante • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Acupuncture and gloves: a new hope against chemo nerve pain?
Prevention Recruiting nowAs a core component of comprehensive breast cancer treatment, chemotherapy frequently induces chemotherapy-induced peripheral neuropathy (CIPN), particularly with taxane-based agents. The incidence of CIPN reaches 68.1% within the first month of chemotherapy, and over 30% of pati…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Herbal hope for ovarian health: new trial tests ancient remedy
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the efficacy and safety of Bushen Yiqi formula combined with dehydroepiandrosterone (DHEA) in the treatment of women with diminished ovarian reserve (DOR). The study also aims to assess the safety profile of this combined therapy.…
Phase 1/2 • Sponsor: Jiangxi University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy offers hope for patients with stubborn low platelet disorder
Disease control Recruiting nowThe primary objective of this trial is to assess the efficacy and safety of combining Romiplostim N01 with Rituximab for the treatment of adult patients with primary immune thrombocytopenia (ITP) whose disease is refractory to oral TPO-RAs. All participants in this study will re…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for bile duct cancer: experimental drug combo enters Mid-Stage trial
Disease control Not yet recruitingThis is an open-label, multicenter Phase II clinical study aimed at evaluating the efficacy, safety, PK profile, and immunogenicity of QLS31905 for Injection combined with Chemotherapy ± QL2107 in Patients with CLDN18.2-positive Advanced Biliary Tract Cancer
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:50 UTC
-
Green tea compounds could soothe radiation burns in cancer care
Symptom relief By invitation onlyIntroduction Radiation-induced dermatitis (RID), which includes both acute and chronic forms, affects up to 95% of patients undergoing radiation therapy. Despite its high incidence, there are currently no validated prevention and management recommendations specifically for the me…
Phase 3 • Sponsor: CARLOS FRANCISCO SAAVEDRA GARCIA • Aim: Symptom relief
Last updated Jun 26, 2026 14:34 UTC
-
Can an AI coach help parents kick the habit?
Disease control Recruiting nowThis study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.
Sponsor: Beijing Normal University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC